Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Gu?rin for patients with high-risk non-muscle invasive bladder cancer.

Jamil ML, Deebajah M, Sood A, Robinson K, Rao K, Sana S, Alanee S. Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Gu?rin for patients with high-risk non-muscle invasive bladder cancer. BMJ Open. 2019 07 17; 9(7):e028287.

View in: PubMed

subject areas

Adult
BCG Vaccine
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Prospective Studies
Research Design
Urinary Bladder Neoplasms

authors with profiles

Akshay Sood

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support